BLEOMYCIN DISPOSITION IN CHILDREN WITH CANCER

被引:13
作者
YEE, GC
CROM, WR
LEE, FH
SMYTH, RD
EVANS, WE
机构
[1] ST JUDE CHILDRENS RES HOSP,CLIN PHARMACOKINET & PHARMACODYNAM SECT,MEMPHIS,TN 38101
[2] BRISTOL MYERS CO LABS,SYRACUSE,NY 13201
关键词
D O I
10.1038/clpt.1983.91
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:668 / 673
页数:6
相关论文
共 25 条
[1]  
ALBERTS DS, 1978, CANCER CHEMOTH PHARM, V1, P177
[2]   NONCOMPARTMENTAL DETERMINATION OF THE STEADY-STATE VOLUME OF DISTRIBUTION [J].
BENET, LZ ;
GALEAZZI, RL .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1979, 68 (08) :1071-1074
[3]  
BENNETT WM, 1980, CANCER TREAT REP, V64, P921
[4]   RENAL AND ELECTROLYTE DISTURBANCES ASSOCIATED WITH CISPLATIN [J].
BLACHLEY, JD ;
HILL, JB .
ANNALS OF INTERNAL MEDICINE, 1981, 95 (05) :628-632
[5]  
BROUGHTON A, 1976, CANCER RES, V36, P1418
[6]  
BROUGHTON A, 1977, CANCER, V40, P2772, DOI 10.1002/1097-0142(197712)40:6<2772::AID-CNCR2820400603>3.0.CO
[7]  
2-1
[8]  
BURGER RM, 1981, LIFE SCI, V28, P715, DOI 10.1016/0024-3205(81)90153-3
[9]   VARIABILITY IN DERIVED PARAMETERS OF FUROSEMIDE PHARMACOKINETICS [J].
CHENNAVASIN, P ;
JOHNSON, RA ;
BRATER, DC .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1981, 9 (05) :623-633
[10]  
CROOKE ST, 1977, CANCER TREAT REP, V61, P1631